Holen Sie sich die Stockscreener-App
1.38
4.17%
-0.06
Handel nachbörslich:
1.43
0.05
+3.62%
Schlusskurs vom Vortag:
$1.44
Offen:
$1.45
24-Stunden-Volumen:
105.06K
Relative Volume:
0.35
Marktkapitalisierung:
$11.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.72M
KGV:
-0.5228
EPS:
-2.6394
Netto-Cashflow:
$-6.25M
1W Leistung:
-5.48%
1M Leistung:
-4.17%
6M Leistung:
-42.02%
1J Leistung:
-31.34%
1-Tages-Spanne:
$1.38
$1.45
1-Wochen-Bereich:
$1.38
$1.54
52-Wochen-Spanne:
$1.275
$4.4899
Edesa Biotech Inc Stock (EDSA) Company Profile
Firmenname
Edesa Biotech Inc
Sektor
Branche
Telefon
(905) 475-1234
Adresse
100 SPY COURT, MARKHAM, ON
Vergleichen Sie EDSA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
1.38 | 12.00M | 0 | -7.72M | -6.25M | -2.6394 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Edesa Biotech Inc Aktie (EDSA) Neueste Nachrichten
Price Action: Is Edesa Biotech Incs growth already priced inJuly 2025 Technicals & Low Risk Growth Stock Ideas - baoquankhu1.vn
Fed Meeting: Can Edesa Biotech Inc sustain earnings growth2025 Top Decliners & Growth Focused Entry Point Reports - baoquankhu1.vn
Bearish Setup: Is PennantPark Investment Corporation a play on infrastructure spendingWeekly Trend Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Buy Signal: Can Edesa Biotech Inc expand into new marketsWeekly Gains Summary & Entry Point Strategy Guides - baoquankhu1.vn
Energy Moves: Is Edesa Biotech Incs growth already priced inJuly 2025 Reactions & Smart Allocation Stock Tips - baoquankhu1.vn
Does Edesa Biotech Inc stock benefit from AI growthEarnings Overview Report & Safe Entry Trade Reports - baoquankhu1.vn
Shorts Report: Will Edesa Biotech Inc stock gain from government policiesMarket Risk Analysis & Accurate Intraday Trade Tips - Bộ Nội Vụ
Is Edesa Biotech Inc. stock positioned for digital transformationShare Buyback & Stepwise Trade Execution Plans - Улправда
Edesa Biotech Inc. (EDSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Edesa Biotech Inc. stock could be next big winnerDaily Trainer Picks & quick comparison of popular models - Улправда
Is Edesa Biotech Inc. stock vulnerable to regulatory risksMarket Performance Recap & Free Reliable Trade Execution Plans - Улправда
Edesa Biotech, Inc.Common Shares (NQ: EDSA - FinancialContent
Published on: 2026-01-06 14:04:13 - ulpravda.ru
Market Recap: How robust is Invesco Bloomberg Analyst Rating Improvers stock financial positionMarket Performance Recap & Long-Term Safe Investment Plans - moha.gov.vn
What is the fair value of Edesa Biotech Inc. stock nowForecast Cut & Community Trade Idea Sharing - Улправда
Is Edesa Biotech Inc. stock supported by strong fundamentals2025 AllTime Highs & Daily Technical Stock Forecast Reports - Улправда
Will Edesa Biotech Inc. stock recover faster than peersBond Market & Stepwise Swing Trade Plans - DonanımHaber
Diluted earnings per share (diluted EPS) of Edesa Biotech, Inc. – BOATS:EDSA - TradingView — Track All Markets
Why analysts remain bullish on Edesa Biotech Inc. stockGap Down & Breakout Confirmation Alerts - Улправда
S P Trends: Is Edesa Biotech Inc. stock supported by strong fundamentals2025 Retail Activity & Low Risk High Win Rate Stock Picks - Улправда
Zacks Small Cap Comments on Edesa Biotech Q1 Earnings - Defense World
Zacks Small Cap Forecasts Edesa Biotech FY2028 Earnings - Defense World
EDSA: Gearing Up to Initiate Phase 2 Vitiligo Trial in Mid-2026 - Zacks Small Cap Research
Edesa Biotech advances dermatology and respiratory programs in fiscal 2025 - MSN
Edesa Biotech Advances Dermatology and Respiratory Programs in Fiscal 2025 - TipRanks
Edesa Biotech increases at-the-market offering limit to $2.26 million - Investing.com
[8-K] Edesa Biotech, Inc. Reports Material Event | EDSA SEC FilingForm 8-K - Stock Titan
[424B5] Edesa Biotech, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
Edesa Biotech, Inc. SEC 10-K Report - TradingView — Track All Markets
Edesa Biotech, Inc. Reports Earnings Results for the Full Year Ended September 30, 2025 - marketscreener.com
Edesa Biotech (NASDAQ: EDSA) details fiscal 2025 results press release - Stock Titan
Edesa Biotech Reports Fiscal Year 2025 Results - The Manila Times
Edesa Biotech, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
How buybacks impact Edesa Biotech Inc. stock valueWeekly Stock Recap & Real-Time Volume Surge Alerts - Newser
Edesa Biotech (EDSA) to Release Earnings on Friday - Defense World
Will Edesa Biotech Inc. stock deliver consistent dividendsBond Market & Weekly High Potential Stock Alerts - Newser
Will Edesa Biotech Inc. stock deliver better than expected guidanceJuly 2025 Chart Watch & Daily Profit Maximizing Trade Tips - newser.com
What technical signals suggest for Edesa Biotech Inc. stock2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
Will Edesa Biotech Inc. stock continue upward momentumJuly 2025 Review & Fast Gaining Stock Reports - newser.com
Is Edesa Biotech Inc. stock affected by interest rate hikesJuly 2025 Gainers & Free Growth Oriented Trading Recommendations - newser.com
Best data tools to analyze Edesa Biotech Inc. stock2025 Fundamental Recap & Safe Swing Trade Setup Alerts - newser.com
Can Edesa Biotech Inc. stock sustain market leadership2025 Momentum Check & Risk Adjusted Swing Trade Ideas - newser.com
Finanzdaten der Edesa Biotech Inc-Aktie (EDSA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):